Theravance Biopharma, Inc.
NASDAQ:TBPH
8.28 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 39.545 | 298.172 | 89.959 | 81.467 | 58.064 | 378.021 | 88.98 | 344.709 | 112.707 | 89.215 | 0 | 0 |
| Short Term Investments
| 62.881 | 29.312 | 83.506 | 211.474 | 222.767 | 127.255 | 259.586 | 156.387 | 59.727 | 165.396 | 0 | 0 |
| Cash and Short Term Investments
| 102.426 | 327.484 | 173.465 | 292.941 | 280.831 | 505.276 | 348.566 | 501.096 | 172.434 | 306.01 | 0 | 0 |
| Net Receivables
| 17.474 | 16.785 | 57.599 | 69.667 | 50.57 | 10.053 | 7.109 | 9.076 | 37.154 | 2.129 | 1.133 | 0.941 |
| Inventory
| 0 | 1.513 | 10.245 | 20.374 | 0 | 0 | 16.83 | 12.22 | 10.005 | 12.546 | 10.406 | 7.514 |
| Other Current Assets
| 13.641 | 7.682 | 8.561 | 10.359 | 7.087 | 17.494 | 5.953 | 3.051 | 5.115 | 8.213 | 2.567 | 2.38 |
| Total Current Assets
| 133.541 | 353.464 | 249.87 | 393.341 | 338.488 | 532.823 | 378.749 | 528.503 | 237.472 | 326.769 | 14.106 | 10.835 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 45.355 | 52.001 | 53.347 | 59.682 | 59.248 | 13.176 | 10.157 | 8.46 | 9.873 | 9.663 | 10.238 | 9.154 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.836 | 0.836 | 67.537 | 12.75 | 4.985 | 11.869 | 41.587 | 91.565 | 50.86 | 51.399 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 202.267 | 201.099 | 4.065 | 3.284 | 6.105 | 2.367 | 10.907 | 10.726 | 1.911 | -50.06 | 0.833 | -9.154 |
| Total Non-Current Assets
| 248.458 | 253.936 | 124.949 | 75.716 | 70.338 | 27.412 | 62.651 | 110.751 | 62.644 | 11.002 | 11.071 | 9.154 |
| Total Assets
| 381.999 | 607.4 | 374.819 | 469.057 | 408.826 | 560.235 | 441.4 | 639.254 | 300.116 | 337.771 | 25.177 | 20.962 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 1.524 | 1.554 | 3.098 | 6.775 | 4.758 | 9.028 | 5.924 | 1.733 | 18.804 | 9.921 | 6.94 | 5.225 |
| Short Term Debt
| 3.923 | 28.715 | 17.443 | 29.201 | 17.613 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -5.447 | 0.024 | 0.098 | 11.523 | 31.575 | 43.402 | 0.125 | 0.152 | 0.144 | 0.089 | 8.207 | 0 |
| Other Current Liabilities
| 24.767 | -1.578 | 37.948 | 76.072 | 57.757 | 46.124 | 56.503 | 47.383 | 30.522 | 31.246 | 21.706 | 17.447 |
| Total Current Liabilities
| 24.767 | 28.715 | 58.587 | 123.571 | 111.703 | 98.554 | 62.552 | 49.268 | 49.47 | 41.256 | 36.853 | 22.672 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 45.236 | 45.407 | 652.075 | 647.056 | 492.915 | 454.353 | 223.746 | 222.676 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0.192 | 0.31 | 0.348 | 6.761 | 26.179 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 70.437 | 64.191 | -0.31 | -0.348 | -6.761 | -26.179 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 28.564 | 27.095 | 2.73 | 2.181 | 28.048 | 58.917 | 39.924 | 17.079 | 7.581 | 6.728 | 5.359 | 0 |
| Total Non-Current Liabilities
| 144.237 | 136.885 | 654.805 | 649.237 | 520.963 | 513.27 | 263.67 | 239.755 | 7.581 | 6.728 | 5.359 | 0 |
| Total Liabilities
| 169.004 | 165.6 | 713.392 | 772.808 | 632.666 | 611.824 | 326.222 | 289.023 | 57.051 | 47.984 | 42.212 | 22.672 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -909.104 | -853.911 | -1,726.043 | -1,526.617 | -1,248.6 | -1,012.145 | -797.74 | -512.225 | -321.556 | -139.337 | -17.035 | -6.99 |
| Accumulated Other Comprehensive Income/Loss
| -0.065 | -0.015 | -0 | 0.047 | 0.145 | -0.166 | -0.733 | -0.253 | -0.07 | -0.082 | 0 | 0 |
| Other Total Stockholders Equity
| 1,122.164 | 1,295.725 | 1,387.469 | 1,222.818 | 1,024.614 | 960.721 | 913.65 | 862.708 | 564.691 | 429.206 | 0 | 0 |
| Total Shareholders Equity
| 212.995 | 441.8 | -338.573 | -303.751 | -223.84 | -51.589 | 115.178 | 350.231 | 243.065 | 289.787 | -17.035 | -6.99 |
| Total Equity
| 212.995 | 441.8 | -338.573 | -303.751 | -223.84 | -51.589 | 115.178 | 350.231 | 243.065 | 289.787 | -17.035 | -6.99 |
| Total Liabilities & Shareholders Equity
| 381.999 | 607.4 | 374.819 | 469.057 | 408.826 | 560.235 | 441.4 | 639.254 | 300.116 | 337.771 | 25.177 | 0 |